Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals. [electronic resource]
Producer: 20120516Description: 423-7 p. digitalISSN:- 1873-5177
- Adolescent
- Adult
- Amphetamine-Related Disorders -- drug therapy
- Attention -- drug effects
- Cognition -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Male
- Methamphetamine -- adverse effects
- Middle Aged
- Neuroprotective Agents -- administration & dosage
- Phenylcarbamates -- administration & dosage
- Rivastigmine
- Time Factors
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.